Patent ID: 9518033
Filing Date: 2016-12-13
CPC Classification: A61P,C07D

Claim Text:
1. A compound of formula A and pharmaceutically acceptable salts thereof, wherein R is selected from the group consisting of hydrogen, alkyl having carbon numbers up to 10, cycloalkyl, aromatic, aromatics having substituents selected from the group consisting of halogen, OH, COOH, OCH 3 , and alkyl, and substituted heterocyclics including heteroaromatics compounds having up to seven members; R 1 is selected from nucleophiles selected from the group consisting of halides, O along with a substituent selected from the group consisting of hydrogen, alkyl having carbon numbers up to 10, cycloalkyl, aromatic, aromatics having substituents selected from the group consisting of halogen, OH, COOH, OCH 3 , and alkyl, and substituted heterocyclics including heteroaromatics compounds having up to seven members, S along with a substituent selected from the group consisting of hydrogen, alkyl having carbon numbers up to 10, cycloalkyl, aromatic, aromatics having substituents selected from the group consisting of halogen, OH, COOH, OCH 3 , and alkyl, and substituted heterocyclics including heteroaromatics compounds having up to seven members, COO along with a substituent selected from the group consisting of hydrogen, alkyl having carbon numbers up to 10, cycloalkyl, aromatic, aromatics having substituents selected from the group consisting of halogen, OH, COOH, OCH 3 , and alkyl, and substituted heterocyclics including heteroaromatics compounds having up to seven members, NR2R3 wherein R2 and R3 are selected from the group consisting of hydrogen, alkyl having carbon numbers up to 10, cycloalkyl, aromatic, aromatics having substituents selected from the group consisting of halogen, OH, COOH, OCH 3 , and alkyl, substituted heterocyclics including heteroaromatics compounds having up to seven members and substituted amino, and alkyl having up to five carbon chain.